FINWIRES · TerminalLIVE
FINWIRES

$ACHC

6 stories mentioning ACHCUpdated 14d ago

Every FINWIRES story that references ACHC, newest first.

Wire

Acadia Healthcare's Operational Turnaround Progressing as New Facilities Open on Schedule, UBS Says

Acadia Healthcare's (ACHC) operational turnaround is advancing, with new facilities opening on schedule and surpassing startup expectations, a "meaningful" improvement from the past couple of years, UBS said in a note emailed Thursday.The turnaround is due to the return of the company's former chief executive officer and chief financial officer, who have focused on execution, accountability, and leadership, UBS analysts said. The changes they have made have boosted facility licensing, payer contracting, and occupancy ramps, resulting in several new facilities reaching positive profit numbers ahead of schedule, the analysts said.The payer environment continues to stabilize, with Acadia stating that it received low- to mid-single-digit rate increases from payers, amid generally strong relationships with managed care organizations, according to the note.However, investors are paying close attention to the Acadia's $28.6 million increase in its professional and general liability reserves, which mostly offset the $26 million benefit from the Florida Directed Payment Program, the analysts said. They noted that the company admits that the situation will be hard to predict even as current-year reserve assumptions remain unchanged.UBS kept the company's stock rating at buy and raised the price target to $41 from $39.Price: $28.61, Change: $+1.26, Percent Change: +4.61%

$ACHC
Wire

UBS Adjusts Price Target on Acadia Healthcare to $39 From $31, Maintains Buy Rating

Acadia Healthcare (ACHC) has an average rating of overweight and mean price target of $29.79, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $31.34, Change: $+0.60, Percent Change: +1.95%

$ACHC
Wire

Acadia Healthcare Shares Rise After Upgrade From Jefferies

Acadia Healthcare's (ACHC) shares were up more than 5% in Wednesday trading after Jefferies upgraded the company's stock to buy from hold and raised its price target to $30 from $24.50.Trading volume stood at over 1.4 million shares against a daily average of roughly 3 million.Price: $25.71, Change: $+1.29, Percent Change: +5.26%

$ACHC
Research

Jefferies Upgrades Acadia Healthcare to Buy From Hold, Adjusts Price Target to $30 From $24.50

Acadia Healthcare (ACHC) has an average rating of overweight and mean price target of $28.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ACHC
Wire

Acadia Healthcare Rebounds After Bad Debt Concerns Clarified, RBC Says

Acadia Healthcare's (ACHC) outlook has improved after management clarified concerns around bad debt following its recent earnings call, RBC Capital Markets said in a Friday note.The brokerage said in a Friday note that the sharp post-earnings selloff was an "overreaction" and that management's follow-up comments walked back earlier "broad-based" bad debt concerns. It added that the issue is instead "not broad-based across payer types or geographies, but rather isolated to a small number of geographies and specific payors."RBC also pointed to potential upside from Florida supplemental payments, which are not yet included in guidance.The brokerage said it is "incrementally more comfortable in ACHC's positioning" given management's focus on operational discipline and added resources to address denial and bad debt issues.RBC raised its price target to $31 from $28 while maintaining an outperform rating.Shares of Acadia were up nearly 2% in Monday trading.Price: $28.39, Change: $+0.54, Percent Change: +1.94%

$ACHC
Research

Raymond James Upgrades Acadia Healthcare to Strong Buy From Outperform, Adjusts Price Target to $39 From $25

Acadia Healthcare Company (ACHC) has an average rating of overweight and mean price target of $28.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ACHC

Track with the FINWIRES app suite